Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 77.214 million compared to CNY 111.290 million a year ago. Operating loss was CNY 10.321 million compared to CNY 10.868 million a year ago. Net loss was CNY 6.150 million compared to CNY 2.400 million a year ago. Basic loss per share from continuing operations was CNY 0.0505 compared to CNY 0.0197 a year ago.